ALX Oncology Holdings Inc

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio is comprised of three approved products and multiple clinical and preclinical product candidates. Approved products include Naglazyme for mucopolysaccharidosis VI, a product wholly developed and commercialized by BioMarin, Aldurazyme for mucopolysaccharidosis I and Orapred prednisolone sodium phosphate oral, a solution for inflammatory conditions. The company is located in Novato, Calif.

Jennerex Biotherapeutics Inc, based in San Francisco, CA, is a global leader in oncolytic immunotherapeutics, specializing in targeting, attacking, and eradicating cancers. Their most advanced product candidate, Pexa Vec, is engineered to selectively infect and replicate in cancer cells by leveraging genetic changes common in cancer cells. In addition to Pexa Vec, Jennerex Biotherapeutics is actively developing their next-generation pipeline, JX 970, which has shown promising tumor debulking effects and a selective preference for tumor tissues in preclinical studies. The company is dedicated to advancing innovative treatments for cancer through strategic partnerships and ongoing research efforts. Generated from the website

Phil Pharmacy Solutions LLC, based in San Francisco, CA, is dedicated to ensuring the protection and privacy of patients' health information in accordance with HIPAA regulations. The company offers a range of services including medication management, treatment coordination, and health care operations to enhance the quality of care while maintaining confidentiality. Emphasizing transparency, Phil Pharmacy Solutions LLC provides patients with a comprehensive Notice of Privacy Practices, outlining their rights regarding personal health information. Additionally, the organization is committed to notifying individuals in the event of a data breach and supports compliance with health oversight activities. Generated from the website